|
Volumn 23, Issue 12, 2015, Pages 746-748
|
Small Molecules Take A Big Step Against Clostridium difficile
|
Author keywords
Clostridium difficile; Ebselen; Inhibitor; Small molecule; TcdB
|
Indexed keywords
ANTIBIOTIC AGENT;
BACTERIAL VACCINE;
BEZLOTOXUMAB;
CLOSTRIDIUM DIFFICILE TOXIN A;
CLOSTRIDIUM DIFFICILE TOXIN B;
EBSELEN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TOXOID VACCINE;
UNCLASSIFIED DRUG;
ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
BACTERIAL SURVIVAL;
CLOSTRIDIUM DIFFICILE INFECTION;
DIARRHEA;
HUMAN;
MICROBIOME;
NONHUMAN;
PEPTOCLOSTRIDIUM DIFFICILE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PSEUDOMEMBRANOUS COLITIS;
SHORT SURVEY;
TOXIC MEGACOLON;
ANIMAL;
CLOSTRIDIUM INFECTIONS;
DRUG EFFECTS;
ISOLATION AND PURIFICATION;
VIRULENCE;
ANIMALS;
ANTI-BACTERIAL AGENTS;
CLOSTRIDIUM DIFFICILE;
CLOSTRIDIUM INFECTIONS;
VIRULENCE;
|
EID: 84961773547
PISSN: 0966842X
EISSN: 18784380
Source Type: Journal
DOI: 10.1016/j.tim.2015.10.009 Document Type: Short Survey |
Times cited : (6)
|
References (7)
|